Posts tagged as:


Tweet- From LexisNexis® Mealey’s™ Daily Legal News. The Food and Drug Administration on Feb. 13 notified Hospira Inc. that the agency has expanded its prohibition against the importation of the company’s Symbiq infusion pumps to include its Plum, GemStar and LifeCare PCA infusion pumps made in Hospira’s Costa Rica manufacturing plant. Hospira reported the expanded […]


TweetNew York Attorney General Eric Schneiderman initiated an investigation recently into whether energy drink manufacturers are deceiving the consuming public with misstatements about the ingredients and health value of its drinks.  He recently issued subpoenas against big names like Pepsi, the manufacturer of Monster Beverage, and Living Essentials, the maker of 5-Hour Energy drink.  The […]

{ 1 comment }

TweetThe FDA recently launched a first-ever plan to speed up the approval of biosimilar drugs in the U.S. as part of the health care overhaul proposed by President Obama over two years ago.  The new initiative represents another effort to bring down the astronomical costs of healthcare. Biosimilar drugs are drugs that are cheaper versions […]


TweetIn the spirit of our upcoming month of humor (starting next week) we are trying something a little different on the round up today. Each item is written with a more comedic approach than usual, sticking to our formula that we use for the Connected Lawcast (Larry King Live for Lawyers meets The Daily […]